Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alfa acquires Anagen's AuraFlex:

This article was originally published in Clinica

Executive Summary

Italian pharmaceutical company Alfa Wassermann has acquired Anagen's AuraFlex automated immunoassay system for an undisclosed amount. UK company Anagen recently went into voluntary liquidation. Alfa Biotech, a wholly-owned Alfa Wassermann subsidiary, will carry on the AuraFlex project and expects to launch the product in the second quarter of 1997. AuraFlex will be marketed by two other subsidiaries of Alfa Wassermann - Alfa Biotech in Italy and Dutch company Schiapparelli Biosystems in the rest of the world.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089829

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel